70%+ of African pharmaceuticals are imported. The continent is investing in domestic manufacturing for essential medicines, vaccines, and generics — backed by the African Medicines Agency. We connect both supply and capacity-building demand.
Trade execution · eligibility profile
Last verified · 2026-05-25
WHO PQ / EMA / FDA / AMA Secretariat
Outbound preferences
Standards gating market access
High-stakes considerations
Why Pharma & Healthcare
Investment opportunities in domestic essential-medicines, vaccines, and generics manufacturing — Nigeria, Egypt, South Africa, Kenya, Morocco.
Pre-screened international suppliers of medical devices, diagnostics, PPE, and cold-chain equipment. AMA / WHO PQ alignment where applicable.
Use cases
Problem: African pharmaceutical manufacturing investment requires deep regulatory expertise (NAFDAC, MCC, WHO PQ) that international investors lack.
Solution: Pre-curated investment opportunities with regulatory roadmaps, ESG documentation, and DFI co-investment alignment.
Pipeline: 8+ pharma manufacturing investments under evaluation
Trade corridors for this sector
FAQ
A 5-minute readiness diagnostic surfaces where you stand, what to fix next, and matches you to opportunities in this sector.
Take the diagnostic
